349 related articles for article (PubMed ID: 30852793)
1. Inter-observer variability of clinical target volume delineation in definitive radiotherapy of neck lymph node metastases from unknown primary. A cooperative study of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) Head and Neck Group.
Trignani M; Argenone A; Di Biase S; Musio D; Merlotti A; Ursino S; Orlandi E; Genovesi D; Bacigalupo A
Radiol Med; 2019 Jul; 124(7):682-692. PubMed ID: 30852793
[TBL] [Abstract][Full Text] [Related]
2. Inter-observer variability of clinical target volume delineation in radiotherapy treatment of pancreatic cancer: a multi-institutional contouring experience.
Caravatta L; Macchia G; Mattiucci GC; Sainato A; Cernusco NL; Mantello G; Di Tommaso M; Trignani M; De Paoli A; Boz G; Friso ML; Fusco V; Di Nicola M; Morganti AG; Genovesi D
Radiat Oncol; 2014 Sep; 9():198. PubMed ID: 25199768
[TBL] [Abstract][Full Text] [Related]
3. Dedicated MRI simulation for cervical cancer radiation treatment planning: Assessing the impact on clinical target volume delineation.
Veera J; Lim K; Dowling JA; O'Connor C; Holloway LC; Vinod SK
J Med Imaging Radiat Oncol; 2019 Apr; 63(2):236-243. PubMed ID: 30506944
[TBL] [Abstract][Full Text] [Related]
4. Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines.
Grégoire V; Evans M; Le QT; Bourhis J; Budach V; Chen A; Eisbruch A; Feng M; Giralt J; Gupta T; Hamoir M; Helito JK; Hu C; Hunter K; Johansen J; Kaanders J; Laskar SG; Lee A; Maingon P; Mäkitie A; Micciche' F; Nicolai P; O'Sullivan B; Poitevin A; Porceddu S; Składowski K; Tribius S; Waldron J; Wee J; Yao M; Yom SS; Zimmermann F; Grau C
Radiother Oncol; 2018 Jan; 126(1):3-24. PubMed ID: 29180076
[TBL] [Abstract][Full Text] [Related]
5. Physical considerations on discrepancies in target volume delineation.
Moeckli R; Sozzi WJ; Mirimanoff RO; Ozsahin M; Zouhair A; Valley JF; Bochud F
Z Med Phys; 2009; 19(4):224-35. PubMed ID: 19962081
[TBL] [Abstract][Full Text] [Related]
6. Inter-observer variability in target delineation increases during adaptive treatment of head-and-neck and lung cancer.
Apolle R; Appold S; Bijl HP; Blanchard P; Bussink J; Faivre-Finn C; Khalifa J; Laprie A; Lievens Y; Madani I; Ruffier A; de Ruysscher D; van Elmpt W; Troost EGC
Acta Oncol; 2019 Oct; 58(10):1378-1385. PubMed ID: 31271079
[No Abstract] [Full Text] [Related]
7. Primary tumor volume delineation in head and neck cancer: missing the tip of the iceberg?
Elicin O; Terribilini D; Shelan M; Volken W; Mathier E; Dal Pra A; Aebersold DM; Fix MK; Manser P
Radiat Oncol; 2017 Jun; 12(1):102. PubMed ID: 28633674
[TBL] [Abstract][Full Text] [Related]
8. Consequences of introducing geometric GTV to CTV margin expansion in DAHANCA contouring guidelines for head and neck radiotherapy.
Hansen CR; Johansen J; Samsøe E; Andersen E; Petersen JBB; Jensen K; Andersen LJ; Sand HMB; Bertelsen AS; Grau C
Radiother Oncol; 2018 Jan; 126(1):43-47. PubMed ID: 28987748
[TBL] [Abstract][Full Text] [Related]
9. Geometric contour variation in clinical target volume of axillary lymph nodes in breast cancer radiotherapy: an AIRO multi-institutional study.
Leonardi MC; Pepa M; Gugliandolo SG; Luraschi R; Vigorito S; Rojas DP; La Porta MR; Cante D; Petrucci E; Marino L; Borzì G; Ippolito E; Marrocco M; Huscher A; Chieregato M; Argenone A; Iadanza L; De Rose F; Lobefalo F; Cucciarelli F; Valenti M; De Santis MC; Cavallo A; Rossi F; Russo S; Prisco A; Guernieri M; Guarnaccia R; Malatesta T; Meaglia I; Liotta M; Tabarelli de Fatis P; Palumbo I; Marcantonini M; Colangione SP; Mezzenga E; Falivene S; Mormile M; Ravo V; Arrichiello C; Fozza A; Barbero MP; Ivaldi GB; Catalano G; Vidali C; Aristei C; Giannitto C; Miglietta E; Ciabattoni A; Meattini I; Orecchia R; Cattani F; Jereczek-Fossa BA
Br J Radiol; 2021 Jul; 94(1123):20201177. PubMed ID: 33882239
[TBL] [Abstract][Full Text] [Related]
10. [Factors influencing clinical target volume delineation of intact breast in intensity-modulated radiotherapy for breast cancer].
Huang XB; Chen JY; Jiang GL
Ai Zheng; 2006 Jan; 25(1):62-5. PubMed ID: 16405751
[TBL] [Abstract][Full Text] [Related]
11. Re-irradiation with curative intent in patients with squamous cell carcinoma of the head and neck: a national survey of usual practice on behalf of the Italian Association of Radiation Oncology (AIRO).
Maddalo M; Bonomo P; Belgioia L; Bacigalupo A; Donato V; Alterio D; Orlandi E; Argenone A; Merlotti A; Musio D; Trignani M; Ursino S; Arcangeli S; Furlan C; Osti MF;
Eur Arch Otorhinolaryngol; 2018 Feb; 275(2):561-567. PubMed ID: 29279949
[TBL] [Abstract][Full Text] [Related]
12. Positron emission tomography for radiation treatment planning.
Grosu AL; Piert M; Weber WA; Jeremic B; Picchio M; Schratzenstaller U; Zimmermann FB; Schwaiger M; Molls M
Strahlenther Onkol; 2005 Aug; 181(8):483-99. PubMed ID: 16044216
[TBL] [Abstract][Full Text] [Related]
13. Patterns of care analysis for head & neck cancer of unknown primary site: a survey inside the German society of radiation oncology (DEGRO).
Müller von der Grün J; Bon D; Rödel C; Balermpas P
Strahlenther Onkol; 2018 Aug; 194(8):750-758. PubMed ID: 29761228
[TBL] [Abstract][Full Text] [Related]
14. Variability of clinical target volume delineation for rectal cancer patients planned for neoadjuvant radiotherapy with the aid of the platform Anatom-e.
Franco P; Arcadipane F; Trino E; Gallio E; Martini S; Iorio GC; Piva C; Moretto F; Ruo Redda MG; Verna R; Tseroni V; Bona C; Pozzi G; Fiandra C; Ragona R; Bertetto O; Ricardi U
Clin Transl Radiat Oncol; 2018 Jun; 11():33-39. PubMed ID: 29928706
[TBL] [Abstract][Full Text] [Related]
15. Intensity-modulated radiation therapy for head-and-neck cancer: the UCSF experience focusing on target volume delineation.
Lee N; Xia P; Fischbein NJ; Akazawa P; Akazawa C; Quivey JM
Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):49-60. PubMed ID: 12909215
[TBL] [Abstract][Full Text] [Related]
16. Metastatic carcinoma in the cervical lymph nodes from an unknown primary site: results of bilateral neck plus mucosal irradiation vs. ipsilateral neck irradiation.
Reddy SP; Marks JE
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):797-802. PubMed ID: 9128954
[TBL] [Abstract][Full Text] [Related]
17. Primary tumor delineation based on (18)FDG PET for locally advanced head and neck cancer treated by chemo-radiotherapy.
Leclerc M; Lartigau E; Lacornerie T; Daisne JF; Kramar A; Grégoire V
Radiother Oncol; 2015 Jul; 116(1):87-93. PubMed ID: 26088157
[TBL] [Abstract][Full Text] [Related]
18. Potential of intensity-modulated radiotherapy to escalate doses to head-and-neck cancers: what is the maximal dose?
Zhou J; Fei D; Wu Q
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):673-82. PubMed ID: 14529771
[TBL] [Abstract][Full Text] [Related]
19. Can FDG-PET assist in radiotherapy target volume definition of metastatic lymph nodes in head-and-neck cancer?
Schinagl DA; Hoffmann AL; Vogel WV; van Dalen JA; Verstappen SM; Oyen WJ; Kaanders JH
Radiother Oncol; 2009 Apr; 91(1):95-100. PubMed ID: 19285354
[TBL] [Abstract][Full Text] [Related]
20. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing.
Eisbruch A; Marsh LH; Dawson LA; Bradford CR; Teknos TN; Chepeha DB; Worden FP; Urba S; Lin A; Schipper MJ; Wolf GT
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):28-42. PubMed ID: 15093896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
